HLA Nov 16, 2020 Somatic Mutations in Lung Cancer Patients With HLA Supertype B44 Influence Immunotherapy Response Nov 2, 2020 Gritstone Oncology Expands Into Phase II Studies With Neoantigen-based Immunotherapy Oct 9, 2020 Eureka Therapeutics Begins Trial Assessing T-cell Therapy in Certain Liver Cancer Patients Apr 1, 2020 OSE Immunotherapeutics Meets Primary Endpoint in Phase III Trial for HLA-A2 Positive Lung Cancer Feb 19, 2020 Study Finds Potential Biomarkers for Checkpoint Inhibitor Response in Melanoma Breaking News California Governor Vetoes Biomarker Test Coverage Bill Massive Bio, Perthera Partner on Biomarker-Based Clinical Trial Matching Autolus Therapeutics, BMS Partner to Develop Cell Therapies Equipped With Safety Switches Personalis, Duke University, Olink Collaborate on Immunotherapy Markers in Gastric Cancer FDA Approves Roche Antibody Test as CDx for Enhertu in HER2-Low Breast Cancer Patients Seneca Therapeutics Cleared by FDA to Start Phase I/II Oncolytic Virus Trial
